Latest news
RGNX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 10:48:50 GMTREGENXBIO (NASDAQ:RGNX) Rating Increased to Hold at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:03 GMTMorgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $18 - news.futunn.comnews.futunn.com · Sat, 08 Aug 2026 01:48:16 GMTREGENXBIO (RGNX) Stock Drops Despite Profit Surprise And Longer Cash Runway - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:56:44 GMTA Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45 - MoomooMoomoo · Fri, 07 Aug 2026 19:06:22 GMTRegenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 17:37:18 GMTREGENXBIO Inc. (RGNX) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 15:55:55 GMTBarclays Reiterates "Equal Weight" Rating for REGENXBIO (NASDAQ:RGNX) - MarketBeatMarketBeat · Fri, 07 Aug 2026 12:30:22 GMT